Biyo Pharma

Hangzhou, China · Founded 2021 · Privately Held (backing)

Developer of innovative drug designed for nervous system disease. Biyo Pharma is based in Hangzhou, China and was founded in 2021. It has raised $14.3 million.

Last price · $/share
—
Implied valuation
—
Total raised
$14.3M
Last round
—

Who backs Biyo Pharma?

8 investors
InvestorType
Lapam CapitalVenture capital
Tailong VCOther
Hangzhou CapitalOther
Shanghai Healthcare CapitalPE / buyout
Jingjie InvestmentOther
Transfar CapitalOther
Shanghai Shangshi Capital Management—
Triwise Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Biyo Pharma investors

8 investors are on record for Biyo Pharma, including Lapam Capital, Tailong VC, Hangzhou Capital and Shanghai Healthcare Capital.

Free account
More of Biyo Pharma with a free account
  • ·Watch Biyo Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Biyo Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View